Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioCorRx (BICX) Assets Average (2016 - 2025)

BioCorRx's Assets Average history spans 15 years, with the latest figure at $7.1 million for Q3 2025.

  • For Q3 2025, Assets Average rose 1166.76% year-over-year to $7.1 million; the TTM value through Sep 2025 reached $7.1 million, up 1166.76%, while the annual FY2024 figure was $387414.0, 32.94% down from the prior year.
  • Assets Average for Q3 2025 was $7.1 million at BioCorRx, up from $6.7 million in the prior quarter.
  • Across five years, Assets Average topped out at $7.1 million in Q3 2025 and bottomed at $353165.5 in Q1 2024.
  • The 5-year median for Assets Average is $854652.0 (2022), against an average of $1.7 million.
  • The largest annual shift saw Assets Average tumbled 57.61% in 2022 before it skyrocketed 1593.76% in 2025.
  • A 5-year view of Assets Average shows it stood at $1.2 million in 2021, then crashed by 34.07% to $792921.5 in 2022, then tumbled by 41.78% to $461666.5 in 2023, then grew by 11.5% to $514755.5 in 2024, then soared by 1280.69% to $7.1 million in 2025.
  • Per Business Quant, the three most recent readings for BICX's Assets Average are $7.1 million (Q3 2025), $6.7 million (Q2 2025), and $3.6 million (Q1 2025).